CLAIRE KYLANDER: Open Payments
NPI 1003581166 · AUSTIN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 44 payments from 10 companies in 2025. Trend: 2023 $1,456 · 2024 $1,254 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 28 | $433 |
| Astellas Pharma US Inc | 5 | $137 |
| Boston Scientific Corporation | 2 | $137 |
| 180 Medical, Inc. | 1 | $80 |
| MILLICENT US INC | 2 | $37 |
| Integra LifeSciences Corporation | 2 | $35 |
| MAYNE PHARMA COMMERCIAL LLC | 1 | $32 |
| COLOPLAST CORP | 1 | $28 |
| ABBVIE INC. | 1 | $28 |
| Medtronic, Inc. | 1 | $22 |
Products named: GEMTESA, Veozah, Axonics, INTRAROSA, OMNIGRAFT, Altis, BOTOX, INTERSTIM.
Industry payments across TX — which companies pay providers there.
